Anne Braae Olesen

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst et al. · The Lancet Respiratory Medicine · 2020 · 612 citations · Full text

Autoimmune Disease, Systemic Scleroderma, Immunology +3

European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes

Robert Knobler, Pia Moinzadeh, Nicolas Hunzelmann et al. · Journal of the European Academy of Dermatology and Venereology · 2017 · 255 citations · Full text

Trends in the incidence of nonmelanoma skin cancer in Denmark 1978–2007: Rapid incidence increase among young Danish women

Fatima Birch‐Johansen, Allan Jensen, Lone Hedegaard Mortensen et al. · International Journal of Cancer · 2010 · 213 citations

Nonmelanoma Skin Cancer, Cancer Epidemiology, Young Danish Women +14

Systemic sclerosis and the risk of cancer: a nationwide population-based cohort study

Anne Braae Olesen, Dóra Körmendiné Farkas, Henrik Toft Sørensen · British Journal of Dermatology · 2010 · 159 citations

Use of photosensitising diuretics and risk of skin cancer: a population-based case–control study

Annette Østergaard Jensen, Henrik F. Thomsen, Malene Cramer Engebjerg et al. · British Journal of Cancer · 2008 · 154 citations · Full text